Neil Weir is the founder of Sitryx Therapeutics. Sitryx Therapeutics has raised $75M in total funding. Latest round: Series B.
Neil Weir is the Executive Chairman and President of Sitryx Therapeutics, a biotechnology company based in Oxford. He has been identified as the CEO in company announcements regarding its financing rounds. His work focuses on immunometabolism therapeutics for chronic autoimmune and inflammatory diseases.
Full founder directory · Investor directory · Company funding database · Fundraising library